학술논문
Retraction Note: High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir therapy: a real-life experience
Document Type
Erratum
Source
In: Archives of virology . (Archives of virology, 13 February 2024, 169(3):45)
Subject
Language
English
ISSN
14328798